Recent Updates
Recently added Catalysts
RDY

Dr. Reddy's Laboratories Ltd. 8-2-337, Road No. 3, Banjara Hills, Hyderabad - 500 034, Telangana, India. CIN: L85195TG1984PLC004507 Tel :+91 40 4900 2900 Fax :+91 40 4900 2999 Email :mail@drreddys.com www.drreddys.com

Key Takeaway: National Stock Exchange of India Ltd. (Scrip BSE Limited (Scrip Code: 500124) Ref: Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Sub: Effective Date of the Scheme of Amalgamation and Arrangement of Dr. Reddy's Hol

Full Press Release Details

National Stock Exchange of India Ltd. (Scrip
BSE Limited (Scrip Code: 500124)
Ref: Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Sub: Effective Date of the Scheme of Amalgamation and Arrangement of Dr. Reddy's Holdings Limited and Dr. Reddy's Laboratories Limited and their respective shareholders ( Scheme')
This is in furtherance to our letter dated
April 7, 2022, wherein we had intimated that the Scheme has been approved by the Hon'ble National Company Law Tribunal ( NCLT')
Hyderabad Bench, vide its Order dated April 5, 2022.
We wish to inform that the Company has
filed the Certified Copy of NCLT Order sanctioning the Scheme with the respective jurisdictional Registrar of Companies in Form
INC-28 today i.e. on April 8, 2022. Therefore, the Effective Date of the Scheme is April 8, 2022.
Further, the Appointed Date of the Scheme
This is for your information.
For Dr. Reddy's Laboratories Limited
/s/ K Randhir Singh
K Randhir Singh
Company Secretary & Compliance Officer
CC: New York Stock Exchange Inc. (Stock
Last updated: Apr 8, 2022